Website of DuPont Intellectual Assets Business DuPont The Miracles of Science
Search Technologies Perform the Search
Contact DuPont Technology Bank Frequently Asked Questions
DuPont Technology Bank Home Search Technologies Featured Technologies What We License Technology of the Week at yet2.com Science
DuPont Technology
WorldwideHome

DuPont Technology 
Overview
Novelty
Development
Intellectual Property
Provider Demographics
Technical Details
Licensing

 Actions
Request an Introduction
Ask the Owner a Question
Email this DuPont Technology to a Friend
Print this DuPont Technology
Return to Search Results
I-MUNETM in vitro Protein Immunogenicity Testing Methods

DuPont is offering to license its extensive portfolio of patents covering in vitro methods and technologies for the characterization of immunogenic properties of proteins and peptides focused on assessing and ranking relative immunogenicity of proteins, assessing and ranking immunogenicity of protein variants, and mapping potential immunogenicity of peptide epitopes. These methods have utility in reducing immunogenicity and allergenicity of industrial polypeptides; reducing immunogenicity of biotherapeutic drugs; and increasing immunogenicity of vaccines.

Benefits Summary

These methods have utility in reducing immunogenicity and allergenicity of industrial polypeptides; reducing immunogenicity of biotherapeutic drugs; and increasing immunogenicity of vaccines. more

Development Summary

Development information was not provided for this TechPak.

IP Summary

This technology is supported by 5 US patents and 4 European patents. more


FAQs Site Map Terms of Use Privacy Statement Contact Us Log In/Register

Bottom Toolbar
Copyright © 2008 DuPont. All rights reserved. The DuPont Oval Logo, DuPont™, The miracles of science™ and all products denoted with ® or ™ are registered trademarks or trademarks of E. I. du Pont de Nemours and Company or its affiliates.

DuPont TechnologyBank™ web site powered by
Visit the yet2.com Technology Marketplace